You just read:

Initial Pharmacokinetic Data From TRIBECA Study Support Potential For Bioequivalence Between Cynviloq And Albumin-Bound Paclitaxel

News provided by

Sorrento Therapeutics, Inc.

14 Oct, 2014, 21:31 BST